04:59 AM EDT, 09/22/2026 (MT Newswires) -- Orange (ORA.PA) unit Orange Ventures invested in the latest funding round for French health technology startup Biolevate, according to a Tuesday release. The transaction supports the French telecommunications company's strategy to support digital and artificial intelligence tools for businesses in the healthcare and life sciences industries. Additionally, Orange Business will partner with Biolevate to combine its agentic AI capabilities with the clinical research, data, and AI expertise of Orange affiliate Enovalife. The collaboration aims to automate clinical trial protocol development, study reports, and regulatory bridging.

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.